- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cediranib
Total 107 results
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
University of GlasgowCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
AstraZenecaCompletedAcute | Leukaemia | Myelocytic
-
NCIC Clinical Trials GroupCompletedColorectal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificCanada
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark
-
AstraZenecaCompletedAdvanced Prostate AdenocarcinomaUnited States
-
AstraZenecaCompletedAdvanced Solid Tumor | Liver MetastasesGermany
-
National Cancer Institute (NCI)Active, not recruitingSarcoma, Alveolar Soft PartUnited States
-
AstraZenecaCompletedTumorsNetherlands, Germany, United Kingdom
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedRefractory Differentiated Thyroid Gland Carcinoma | Unresectable Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
University Health Network, TorontoAstraZenecaCompleted
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Shin Poong Pharmaceutical Co. Ltd.Medicines for Malaria VentureUnknown
-
AstraZenecaCompletedColorectal CancerCzech Republic, France, Italy, Spain, United Kingdom, Germany, Canada, Austria, Belgium
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
NCIC Clinical Trials GroupCompletedColorectal Cancer | Lung CancerCanada
-
National Cancer Institute (NCI)RecruitingBreast Neoplasms | Colorectal NeoplasmsUnited States
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
AstraZenecaCompletedBrain Tumor | Recurrent GlioblastomaUnited States, United Kingdom
-
The Christie NHS Foundation TrustClinical Trials Unit, ManchesterCompleted
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University Health Network, TorontoAstraZenecaCompletedOvarian CancerCanada
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma... and other conditionsUnited States
-
CCTU- Cancer ThemeAstraZeneca; Cancer Research UK; University of CambridgeRecruiting
-
University Health Network, TorontoAstraZenecaActive, not recruitingPancreatic Adenocarcinoma | Leiomyosarcoma | Mismatch Repair Proficient Colorectal CancerCanada
-
AstraZenecaCompletedMetastatic Colorectal CancerBrazil, Bulgaria, Czech Republic, Korea, Republic of, Poland, United Kingdom, Philippines, China, Germany, Hungary, Argentina, Taiwan, Switzerland, Australia, India
-
University of OxfordAstraZenecaCompletedOvarian CancerUnited Kingdom
-
Medicines for Malaria VentureShin Poong PharmaceuticalsTerminated
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaUnknown
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
AstraZenecaCompletedAdvanced Breast CancerUnited States, Australia, Brazil
-
National Cancer Institute (NCI)AstraZenecaActive, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Advanced Malignant Solid Neoplasm | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Stage IIIA Lung Non-Small... and other conditionsUnited States, Canada
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
University of ManchesterCardiff University; AstraZenecaActive, not recruitingEndometrial Neoplasms | CarcinosarcomaUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid TumorUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology GroupCompletedAdult Glioblastoma | Adult GliosarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingEpithelioid Mesothelioma | Pleural Malignant Mesothelioma | Sarcomatoid Mesothelioma | Recurrent Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Fallopian Tube Carcinoma | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Ovarian Serous Surface Papillary AdenocarcinomaUnited States
-
AstraZenecaCompletedColorectal CancerVietnam, United States, Australia, Czech Republic, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Philippines, Germany, Hungary, Latvia, Ukraine, Finland, Austria, Belgium, Canada, Israel, Sl... and more
-
National Cancer Institute (NCI)Active, not recruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Primary Peritoneal Carcinoma | Ovarian High Grade Serous Adenocarcinoma | Primary Peritoneal Endometrioid Adenocarcinoma | Ovarian...United States